Equity · Healthcare
AbbVie Inc. (ABBV) perpetual futures
ABBV perpetual futures on 1 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade ABBVUSDT.
AbbVie Inc. is a global biopharmaceutical company developing and commercializing advanced medicines for immunology, oncology, virology, gastroenterology, neurology, and other therapeutic areas.
Price chart
Use the left and right arrow keys to inspect points on the chart.
Trading data
Perpetual market activity
1/2 live markets
Trading data
Perpetual market activity
Spot performance
Venue matrix
2 markets
Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.
Gate.io
BingXTokenized wrappers of the real stock, tradable on-chain and on crypto exchanges around the clock. Premium/discount compares the token price to our stock reference price. Data: CoinMarketCap · Robinhood · DexScreener · GeckoTerminal.
| Product | Price | Premium vs stock | 24h Vol. | Market Cap | Chains |
|---|---|---|---|---|---|
| ABBVonOndo GM | $291.07 | +2.27% | $115k | $9k | Ethereum · BNB Smart Chain (BEP20) · Solana |
| ABBVXxStocks | $275.95 | -3.05% | $72k | $264k | Solana · Arbitrum · BNB Smart Chain (BEP20) · Ink |
Tradability
Execution quality
Entry cost and depth per venue at $1k–$100k
Tradability
Execution quality
Entry cost and depth per venue at $1k–$100kNo sufficient depth · 0 of 1 venues absorb $10k
No fresh book data: Gate.io
Taker execution estimate incl. approx. fees - maker fills are not guaranteed.
Best venues for this underlying
Best liquidity
ABBVTightest spread
ABBVHighest volume
ABBVFunding history
Stored venue snapshots by market
Funding history
Stored venue snapshots by marketCompany data
Company fundamentals
Updated 1h ago
Company data
Company fundamentals
More metrics
Fundamental detail
Annual + quarterlyRefreshed 1h ago
Charts: revenue, profit, cash flow & valuation
Next catalyst
Catalysts
Next catalyst
Catalysts
No unusual perp activity right now.
Research data
Analysts, filings and peer context
Research data
Analysts, filings and peer context
Estimates
6Company events
6Peer comparison
Similar listed perpsRevenue mix
PendingAnalysts
PendingOwnership
ABBV-PERPFilings
PendingTranscripts
PendingCompany news
Reuters, WSJ, Bloomberg and FT first, as far as our news provider delivers them; other publishers behind the second filter. Headlines link to the publisher.No articles from Reuters, WSJ, Bloomberg or FT for this company in our feed.
FMP company data
Company intelligence
Updated: Oct 19, 2026, 09:12 AM UTC
FMP company data
Company intelligence
Company profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Chief executive
- Robert A. Michael
- Employees
- 57,000
- IPO date
- Jan 2, 2013
- Country
- US
- Exchange
- New York Stock Exchange
Rating factors
- Return on equityi
- 1
- Return on assetsi
- 4
- Debt to equityi
- 1
- Price to earningsi
- 1
- Price to booki
- 1
Company press releases
Congressional disclosures
Senate
House
Market cap history
Largest fund holders
| Fund | Weight | Shares held |
|---|---|---|
| VTI | 0.61% | 56.2M |
| VOO | 0.68% | 46.9M |
| VCPA.S | 0.66% | 30.8M |
| IVV | 0.72% | 23.5M |
| XAW.TO | 0.44% | 23.5M |
| XWD.TO | 0.54% | 23.5M |
| XUS.TO | 0.72% | 23.5M |
| 1657.T | 0.56% | 23.5M |
| SPY | 0.74% | 21.6M |
| FXAIX | 0.68% | 20.9M |
| VTV | 1.65% | 16.9M |
| VSCA.S | 0.45% | 13.6M |
Analyst track record
How the analysts covering ABBV have done: ratings, price-target accuracy and the measured reaction after their calls.
| 12 months | 3 years | |
|---|---|---|
| Ratings | 217 | 522 |
| Analysts | 33 | 46 |
| Buy / hold / sell | 173 / 44 / 0 | 384 / 138 / 0 |
| Upgrades / downgrades / initiations | 5 / 3 / 5 | 14 / 8 / 12 |
| Price targets hit / missed | 144 / 52 (73%) | 408 / 53 (89%) |
| Avg. return after a rating (TipRanks) | +6.6% | +26.8% |
| Best / worst call | +39.6% / -11.4% | +222.0% / -11.4% |
After buy calls on this stock: median 21-day move +3.4% vs S&P 500 +1.3% (n = 364)
Most accurate on this stock
Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.
- Mohit BansalWells Fargo100% hit rate on this stock · 29 targets measuredBuytarget $300Oct 15, 2026
- Carter GouldCantor Fitzgerald100% hit rate on this stock · 19 targets measuredBuytarget $290Oct 8, 2026
- Evan SeigermanBMO Capital100% hit rate on this stock · 16 targets measuredBuytarget $300Oct 12, 2026
Latest ratings
Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.
TipRanks data via FMP · computed Oct 16, 2026 · 217 ratings
Frequently asked questions
Where can I trade ABBV perpetual futures?
AbbVie Inc. (ABBV) perpetual futures trade on 1 crypto venues, including Gate.io. PerpEquities compares them by live price, funding rate, open interest and liquidity.
Can I trade ABBV around the clock?
Yes. Unlike the underlying stock, ABBV perpetuals trade 24/7 — including weekends and outside regular market hours.
What is the funding rate on ABBV perpetuals?
Right now the ABBV perp funding rate is 0.0% annualized (venue median), ranging from 0.0% to 0.0% across 1 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.
How does the ABBV perp price compare to the AbbVie Inc. stock?
The venue-median ABBV perp mark is $284.6 versus a reference stock price of $284.6, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.
What is a ABBV perpetual future?
A ABBV perpetual is a derivative that tracks the price of AbbVie Inc. with no expiry date. It lets you take long or short exposure to AbbVie Inc. on crypto venues, around the clock.
What is ABBVUSDT perpetual?
ABBVUSDT is the symbol most crypto exchanges use for the AbbVie Inc. perpetual settled in USDT (Tether). It tracks the ABBV share price through an index, trades 24/7 with leverage and never expires.
Embed this asset
<a href="https://perpequities.com/stocks/abbv-perp"><img src="https://perpequities.com/badge/abbv-perp.svg" width="240" height="64" alt="ABBV perpetuals · perpequities.com" loading="lazy"></a>